Literature DB >> 13885491

Plasma-alkaline-phosphatase in normal adults and in patients with primary hyperparathyroidism.

C E DENT, C M HARPER.   

Abstract

Entities:  

Keywords:  PERETHYROID GLANDS/diseases; PHOSPHATASES/blood

Mesh:

Substances:

Year:  1962        PMID: 13885491     DOI: 10.1016/s0140-6736(62)91544-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  HYPERPARATHYROIDISM AND CANCER.

Authors:  C E DENT; L C WATSON
Journal:  Br Med J       Date:  1964-07-25

2.  LATE POST-GASTRECTOMY SYNDROMES. POSTGASTRECTOMY BONE DISEASE.

Authors:  C G CLARK
Journal:  Proc R Soc Med       Date:  1964-07

3.  Ethanolamine phosphate excretion in a family with hypophosphatasia.

Authors:  R A GOYER
Journal:  Arch Dis Child       Date:  1963-06       Impact factor: 3.791

4.  Bone and ageing.

Authors:  J Dequeker
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

Review 5.  Alkaline phosphatase.

Authors:  T W Warnes
Journal:  Gut       Date:  1972-11       Impact factor: 23.059

6.  Plasma calcium, magnesium, phosphorus, and alkaline phosphatase levels in normal British schoolchildren.

Authors:  J M Round
Journal:  Br Med J       Date:  1973-07-21

7.  Concerning the question of individual constancy and individual specificity of three serum enzyme activities (serum cholinesterase EC 3.1.1.8, ceruloplasmin EC 1.10.3.2, and alkaline phosphatase EC 3.1.3.1).

Authors:  D Hosenfeld; E Schröter
Journal:  Humangenetik       Date:  1970

8.  Intermittent hyperparathyroidism.

Authors:  T B Connor; J W Clark; L G Martin; H Lovice
Journal:  Trans Am Clin Climatol Assoc       Date:  1966

9.  Effect of treatment on renal function in severe osteomalacia due to Wilson's disease.

Authors:  P Monro
Journal:  J Clin Pathol       Date:  1970-09       Impact factor: 3.411

10.  Bone loss in primary hyperparathyroidism.

Authors:  C I Gryfe
Journal:  Can Med Assoc J       Date:  1973-09-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.